Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1
- PMID: 3422054
Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1
Abstract
The bryostatins, macrocyclic lactones isolated on the basis of their antineoplastic activity, activate protein kinase C in vitro and inhibit phorbol ester binding to the enzyme. In intact cells, the bryostatins induce some phorbol ester responses, such as neutrophil activation, but paradoxically they not only fail to induce other responses, e.g., differentiation in HL-60 promyelocytic leukemia cells, but actually block response to the phorbol esters. We compare here bryostatin I and phorbol 12,13-dibutyrate as inhibitors of cell-cell communication in cultured primary mouse epidermal cells. Like phorbol 12,13-dibutyrate, bryostatin I at nanomolar concentrations markedly inhibited cell coupling. It differed from the phorbol esters, however, in that its action was more transient. By 4 h of incubation bryostatin 1 caused little inhibition of coupling. Moreover, coincubation of bryostatin 1 and phorbol 12,13-dibutyrate gave no greater response at this time than that found for bryostatin 1 alone. Time-dependent inhibition of the protein kinase C pathway could account for many of the observed differences between the actions of the phorbol esters and bryostatin 1.
Similar articles
-
Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells.Cancer Res. 1987 Oct 15;47(20):5445-50. Cancer Res. 1987. PMID: 2888531
-
Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.Cancer Res. 1988 Jul 1;48(13):3702-8. Cancer Res. 1988. PMID: 3132318
-
Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.Cancer Res. 1987 Nov 15;47(22):6006-9. Cancer Res. 1987. PMID: 3478136
-
Protein kinase C in signal transduction and carcinogenesis.Prog Clin Biol Res. 1994;387:3-19. Prog Clin Biol Res. 1994. PMID: 7972255 Review. No abstract available.
-
[The effect of phorbol esters on cell functions].Postepy Biochem. 1989;35(3):265-77. Postepy Biochem. 1989. PMID: 2700788 Review. Polish. No abstract available.
Cited by
-
Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.Br J Cancer. 1991 Oct;64(4):671-6. doi: 10.1038/bjc.1991.379. Br J Cancer. 1991. PMID: 1911215 Free PMC article.
-
Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.Mol Carcinog. 2016 Dec;55(12):2183-2195. doi: 10.1002/mc.22460. Epub 2016 Feb 9. Mol Carcinog. 2016. PMID: 26859836 Free PMC article.
-
Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.Biochem Pharmacol. 2013 Feb 1;85(3):313-24. doi: 10.1016/j.bcp.2012.10.028. Epub 2012 Nov 9. Biochem Pharmacol. 2013. PMID: 23146662 Free PMC article.
-
Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents.Br J Cancer. 1992 Jul;66(1):10-9. doi: 10.1038/bjc.1992.209. Br J Cancer. 1992. PMID: 1637658 Free PMC article. Review. No abstract available.
-
The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line.Biochem Pharmacol. 2011 Jun 1;81(11):1296-308. doi: 10.1016/j.bcp.2011.03.018. Epub 2011 Mar 30. Biochem Pharmacol. 2011. PMID: 21458422 Free PMC article.